|
- iPLEDGE REMS - Home
The iPLEDGE REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure The REMS is required by the U S Food and Drug Administration (FDA) to ensure the benefits of isotretinoin outweigh its risks
- Select Authentication System - iPLEDGE PROGRAM
The iPLEDGE PROGRAM REMS (Risk Evaluation and Mitigation Strategy) The iPLEDGE PROGRAM REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure
- iPLEDGE® REMS | Accutane®
Patients taking Accutane must register in the iPLEDGE® Pregnancy Registry at 1-866-495-0654 or www ipledgeprogram com See your healthcare provider for further information
- iPledge REMS Program - Home View
United Biosource Corporation, Copyright 2020 Application Version 2 6 0
- ipledge
iPledge is a program designed to prevent fetal exposure to isotretinoin through strict guidelines and education for patients, prescribers, and pharmacies
- Login Form - ipledgeonline. org
Upon your initial login for this year, please reset your password first by clicking on the lower right blue box labeled: recover my username password login username
- McKesson - Secure File Transfer Web Client - Login
This system is for the use of authorized users only Individuals using this computer system without authority, or in excess of their authority, are subject to having all of their activities on this system monitored and recorded by systems personnel In the, course of monitoring individuals improperly using this system, or in the course of system maintenance, the activities of authorized users
- iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) | FDA
Health care providers must assign and confirm their currently enrolled patients’ risk category for each patient upon their first login into the iPLEDGE REMS Website on or after December 13,
|
|
|